|
Market Closed -
Nasdaq
06:00:00 24/06/26 am AEST
|
5-day change | 1st Jan Change | ||
| 40.50 USD | +0.80% |
|
-.--% | +61.94% |
| 25/06 | Swiss Market Index Extends Rally; OC Oerlikon Shares Gain | MT |
| 25/06 | Eli Lilly Completes Acquisition of Centessa Pharmaceuticals | MT |
| Market Cap | 6.27B 5.61B 5.18B 4.69B 8.76B 597B 8.9B 61.78B 24.65B 312B 23.52B 23.02B 989B | P/E 2024 |
-8.13x | P/E 2025 | -17.2x |
|---|---|---|---|---|---|
| Enterprise Value | 6.09B 5.46B 5.03B 4.55B 8.52B 580B 8.65B 60.04B 23.95B 304B 22.86B 22.37B 961B | EV / Sales 2024 |
-
| EV / Sales 2025 | 231,810,355x |
| Free-Float |
78.43% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | +0.80% | ||
| 6 months | +2.66% | ||
| Current year | +61.94% |
| Current year | 21.5 |  | 40.56 |
| 1 year | 17.05 | | 40.56 |
| 3 years | 5.58 | | 40.56 |
| 5 years | 2.88 | | 40.56 |
| 10 years | 2.88 | | 40.56 |
| Manager | Title | Age | Since |
|---|---|---|---|
Charlene Stoudt
CTO | Chief Tech/Sci/R&D Officer | - | 01/10/2024 |
Tia Bush
CTO | Chief Tech/Sci/R&D Officer | 55 | 01/03/2023 |
David Chao
ADM | Chief Administrative Officer | 58 | 01/04/2021 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | - | 24/06/2026 | |
Kristina Wright
BRD | Director/Board Member | - | 24/06/2026 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 24/6/26 | Medicxi Ventures (Jersey) Ltd.
| Sell | Company | -19,963,157 | 12.9020% | |
| 1/5/26 | Tax | Chief Executive Officer | -604 | 0.0004% | ||
| 26/3/26 | Exercice | Executive/Senior Manager | 71,994 | 0.0539% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.80% | -.--% | +68.89% | +558.54% | 6.27B | |
| +0.34% | +1.12% | +34.75% | +61.06% | 64.38B | |
| -0.17% | +2.66% | +14.32% | +83.58% | 56.16B | |
| +1.06% | +2.50% | +15.97% | +107.90% | 54.16B | |
| -1.43% | -1.17% | +26.27% | +52.86% | 45.33B | |
| -0.48% | -2.80% | +18.01% | +117.99% | 42.25B | |
| +0.82% | +1.37% | +227.94% | +922.41% | 40.78B | |
| +0.75% | +44.44% | +107.61% | +91.81% | 33.8B | |
| -0.26% | -2.57% | +12.55% | +45.18% | 32.25B | |
| -1.29% | -2.88% | +21.60% | -11.92% | 23.57B | |
| Average | +0.02% | +4.24% | +54.79% | +202.94% | 39.89B | |
| Weighted average by Cap. | +0.03% | +3.57% | +50.48% | +168.56% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | - | 15 13.44 12.4 11.22 20.97 1.43K 21.31 147.88 59 747.56 56.29 55.1 2.37K |
| Net income | -236M -211M -195M -176M -330M -22.45B -335M -2.32B -927M -11.75B -885M -866M -37.21B | -198M -177M -163M -148M -276M -18.81B -281M -1.95B -777M -9.84B -741M -726M -31.18B |
| Net Debt | -364M -326M -301M -272M -509M -34.7B -518M -3.59B -1.43B -18.16B -1.37B -1.34B -57.51B | -176M -158M -146M -132M -246M -16.78B -250M -1.74B -693M -8.78B -661M -647M -27.81B |
Employees
129
- Stock Market
- Stocks
- CNTA Stock
Select your edition
All financial news and data tailored to specific country editions
